Sociodemographic, Clinical, and Behavioral Factors Associated with Sexual Transmitted Infection among HIV-1 Positive Migrants in Portugal: Are There Differences between Sexes?PATHOGENSIF3.32024-07-190OAAI
Determinants of HIV late presentation among men who have sex with men in Portugal (2014-2019): who's being left behind?FRONTIERS IN PUBLIC HEALTHIF3.42024-02-292OAAI
Viral genetic clustering and transmission dynamics of the 2022 mpox outbreak in PortugalNATURE MEDICINEIF502023-09-1118OAAI
HIV-1-Transmitted Drug Resistance and Transmission Clusters in Newly Diagnosed Patients in Portugal Between 2014 and 2019FRONTIERS IN MICROBIOLOGYIF4.52022-04-258OAAI
The demise of multidrug-resistant HIV-1: the national time trend in PortugalJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62012-12-098OAAI
Abacavir versus zidovudine combined with lamivudine and efavirenz, for the treatment of antiretroviral-naive HIV-infected adultsCLINICAL INFECTIOUS DISEASESIF7.32004-10-01194OAAI
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patientsCLINICAL INFECTIOUS DISEASESIF7.32004-08-1510OAAI
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patientsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52004-01-0141OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向